<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Understanding Schizophrenia</title>
  <link rel="stylesheet" href="styles.css">
  <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
</head>
<body>
  <header>
    <h1>Understanding Schizophrenia</h1>
    <p>A Presentation by Anran HUANG (Ann) for PSYC5009 Assessment 1</p>
  </header>

  <nav>
    <a href="#" onclick="showSection('intro')">Introduction</a>
    <a href="#" onclick="showSection('background')">Background</a>
    <a href="#" onclick="showSection('diagnosis')">Diagnosis</a>
    <a href="#" onclick="showSection('treatment')">Treatment</a>
    <a href="#" onclick="showSection('conclusion')">Conclusion</a>
  </nav>

  <section id="intro" class="active">
    <div class="card-container">
        <div class="card active">
            <div class="content-column">
                <h2>Schizophrenia</h2>
                <p>A serious and complex mental health disorder that affects perception, thinking, and behavior.</p>
                <img src="https://www.shutterstock.com/image-vector/paranoia-schizophrenia-mental-illness-abstract-260nw-2447194753.jpg" alt="Understanding Schizophrenia" style="max-width: 100%; height: auto; margin: 20px 0;">
            </div>
        </div>
        <div class="card facts-card">
            <div class="agenda-column">
                <h2>7 Schizophrenia Facts</h2>
                <ul class="facts-list">
                    <li class="fact-item">Schizophrenia is not a split personality.</li>
                    <li class="fact-item">Schizophrenia is one of the top 15 leading causes of disability worldwide.</li>
                    <li class="fact-item">People living with schizophrenia die between 10 and 15 years earlier than the general population.</li>
                    <li class="fact-item">Each individual's experience with schizophrenia is unique.</li>
                    <li class="fact-item">People with schizophrenia are more likely to be victims of violence than perpetrators.</li>
                    <li class="fact-item">Schizophrenia is a spectrum disorder, which means that the symptoms can vary widely from person to person.</li>
                    <li class="fact-item">There is hope: It is possible to live a full and meaningful life even if diagnosed with schizophrenia.</li>
                </ul>
            </div>
        </div>
    </div>

    <script src="script.js"></script>
    <script>
        const factsCard = document.querySelector('.facts-card');
        const factItems = document.querySelectorAll('.fact-item');
        let factIndex = 0;

        factsCard.addEventListener('click', () => {
            if (factIndex < factItems.length) {
                factItems[factIndex].style.display = 'block';
                factIndex++;
            }
        });
    </script>

  </section>

  <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
<script>
  document.addEventListener('DOMContentLoaded', function() {
    const ctx = document.getElementById('prevalenceChart').getContext('2d');
    const prevalenceChart = new Chart(ctx, {
      type: 'bar',
      data: {
        labels: ['Worldwide', 'Adults (Worldwide)', 'Adults (Australia)'],
        datasets: [{
          label: 'Prevalence (%)',
          data: [0.32, 0.45, 0.24],
          backgroundColor: [
            'rgba(204, 121, 167, 0.7)', // Okabe-Ito pink
            'rgba(0, 158, 115, 0.7)',   // Okabe-Ito green
            'rgba(230, 159, 0, 0.7)'    // Okabe-Ito orange
          ],
          borderColor: [
            'rgb(204, 121, 167)',       // Okabe-Ito pink
            'rgb(0, 158, 115)',         // Okabe-Ito green
            'rgb(230, 159, 0)'          // Okabe-Ito orange
          ],
          borderWidth: 1
        }]
      },
      options: {
        responsive: true,
        maintainAspectRatio: false,
        scales: {
          y: {
            beginAtZero: true,
            title: {
              display: true,
              text: 'Percentage (%)',
              font: {
                size: 16,
                weight: 'bold'
              }
            },
            ticks: {
              font: {
                size: 14
              }
            },
            grid: {
              display: false
            }
          },
          x: {
            ticks: {
              font: {
                size: 14
              }
            },
            grid: {
              display: false
            }
          }
        },
        plugins: {
          title: {
            display: true,
            text: 'Prevalence of Schizophrenia (World Overall, Adults vs Australian Adults)',
            font: {
              size: 18,
              weight: 'bold'
            },
            padding: {
              bottom: 20
            }
          },
          legend: {
            display: false
          }
        }
      }
    });
  });
</script>

<style>
  #prevalenceChart {
    height: 650px !important;
  }
</style>

<section id="background" style="padding: 20px; display: flex; flex-direction: column; align-items: center;">
  <!-- <div style="max-width: 800px; width: 100%;"> -->
  <div class="blog-content-wrapper">
  <div>
    <h2>Prevalence and Demographics</h2>
    <p>Schizophrenia affects about 0.3%–0.7% of the population worldwide. The disorder typically manifests in late adolescence or early adulthood, with slightly higher rates in urban areas and among certain demographic groups.</p>
    <canvas id="prevalenceChart" width="400" height="300"></canvas>
    <p style="font-size: 0.9em; color: #777;">Source: [Insert your source here]</p>
  </div>

  <div>
    <h2>History and Evolving Understanding</h2>
    <p>Schizophrenia has been documented for centuries under different names. Key figures such as Emil Kraepelin and Eugen Bleuler laid the foundation for what we know today.</p>
    <div class="timeline">
      <div class="timeline-event">
        <strong>Late 19th Century:</strong> 
        <p>Early recognition of schizophrenia as a distinct illness.</p>
        <img src="https://www.nlm.nih.gov/hmd/topics/diseases-of-mind/images/chainedtowall_101436547.jpg" alt="History" style="max-width: 180px; height: auto; margin-top: 5px;">
      </div>
      <div class="timeline-event">
        <strong>1896:</strong> <p>Emil Kraepelin classifies "dementia praecox."</p>
        <img src="https://encrypted-tbn2.gstatic.com/images?q=tbn:ANd9GcQz3eIldZ9Mp4fr5BWaMYnW4S0N2Ag7hdOqIEIYeC6HrV6Eb86Q9zEFcNlA8boMX9psVp3EviFgzof8kRfBc_HDRA" alt="Emil Kraepelin" style="max-width: 180px; height: auto; margin-top: 5px;">
      </div>
      <div class="timeline-event">
        <strong>1908:</strong> <p>Eugen Bleuler coins the term "schizophrenia."</p>
        <img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTfPtg-3t12Edl-yg8GgKOd1p49rB6PcsS3l60QKEIZyAWwrdn61cG_k3xBGOus52aoFKt3U0MDfLLxPVbeGtSe2w" alt="Eugen Bleuler" style="max-width: 180px; height: auto; margin-top: 5px;">
      </div>
      <div class="timeline-event">
        <strong>Early-mid 1900s:</strong> <p>Lifetime confinement in asylums was common.</p>
        <img src="https://media.npr.org/assets/img/2024/04/14/allison-building-sleeping-porch--1400x810.jpg?sfvrsn=e38692db_5" alt="Asylum" style="max-width: 600px; height: auto; margin-top: 5px;">
      </div>
      <div class="timeline-event">
        <strong>1950s:</strong> <p>Discovery of first antipsychotic medication (Chlorpromazine).</p>
        <img src="https://www.bap.org.uk/articles/wp-content/uploads/2016/10/publicinfo_chlorpromazine3.gif" alt="Chlorpromazine" style="max-width: 600px; height: auto; margin-top: 5px;">
      </div>
      <div class="timeline-event">
        <strong>Late 20th Century:</strong> <p>Shift to de-institutionalization and community care.</p>
        <img src="https://images.everydayhealth.com/images/emotional-health/schizophrenia/who-should-be-on-your-schizophrenia-care-team-alt-1440x810.jpg?sfvrsn=e38692db_5" alt="Community" style="max-width: 600px; height: auto; margin-top: 5px;">
      </div>
      <div class="timeline-event">
        <strong>Late 20th/Early 21st Century:</strong> <p>Advances in neuroscience, understanding complex factors.</p>
        <img src="https://images.newscientist.com/wp-content/uploads/2021/11/16123327/pri210550131.jpg" alt="Brain" style="max-width: 600px; height: auto; margin-top: 5px;">
      </div>
      <div class="timeline-event">
        <strong>Today:</strong> <p>Schizophrenia understood as a complex, multifactorial spectrum.</p>
        <img src="https://m.media-amazon.com/images/I/51CJu3t4PvL._AC_UF894,1000_QL80_.jpg" alt="Spectrum" style="max-width: 400px; height: auto; margin-top: 5px;">
      </div>
    </div>
  </div>
  <div>
    <h2>Etiology: Causes and Risk Factors</h2>
    <p>Schizophrenia is a complex condition, and the exact cause is unknown. There is no single simple cause. Instead, schizophrenia emerges from a complex interplay of biological, genetic, psychological, and environmental factors.</p>
    
    <div class="etiology-overlap">
      <div id="biologicalFactor" class="factor biological">Biological</div>
      <div id="geneticFactor" class="factor genetic">Genetic</div>
      <div id="psychologicalFactor" class="factor psychological">Psychological</div>
      <div id="environmentalFactor" class="factor environmental">Environmental</div>
    </div>
    <div id="etiologyInfo">
    </div>
  </div>
</section>

<section id="diagnosis" class="blog-section">
  <div class="blog-content-wrapper">
    <h1>Symptoms</h1>
    <img src="https://i0.wp.com/post.medicalnewstoday.com/wp-content/uploads/sites/3/2022/06/stages_schizophrenia_GettyImages1338339014_Header-1024x575.jpg?w=1155&h=1528" alt="Schizophrenia Symptoms" style="width: 100%; height: auto; margin: 20px 0;">  
    <div class="info-block">
      <p>📋 <strong>Psychosis</strong> is a collection of symptoms that are characterized by a loss of contact with reality.</p>
    </div>
    <p>Psychosis is the hallmark of schizophrenia. It is characterized by a disconnect between what a person sees, hears, or feels and what is actually there. This can manifest in various ways:</p>
    <div class="symptoms-tabs">
      <div class="tab">
        <button class="tab-button" onclick="toggleTab('positive')">Positive symptoms</button>
        <div id="positive" class="tab-content">
          <div class="sub-tab">
            <button class="sub-tab-button" onclick="toggleSubTab('hallucinations')">Hallucinations</button>
            <div id="hallucinations" class="sub-tab-content">
              <p>Hear, see, or feel things that are not there.</p>
              <iframe width="560" height="315" src="https://www.youtube-nocookie.com/embed/N3jo-0bdSsY?si=LzUKt-ZZ4p5fsK5u&amp;start=274&amp;end=310" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
            </div>
          </div>

          <div class="sub-tab">
            <button class="sub-tab-button" onclick="toggleSubTab('delusions')">Delusions</button>
            <div id="delusions" class="sub-tab-content">
              <p>Believing things that are not true.</p>
              <iframe width="560" height="315" src="https://www.youtube-nocookie.com/embed/fJMOySCn5ho?si=Mbsv56X9lq9jSSfM&amp;start=307&amp;end=375" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
            </div>
          </div>

          <div class="sub-tab">
            <button class="sub-tab-button" onclick="toggleSubTab('disorganizedSpeech')">Disorganized Thinking / Speech</button>
            <div id="disorganizedSpeech" class="sub-tab-content">
              <p>Speaking in a way that is hard to understand.</p>
              <iframe width="560" height="315" src="https://www.youtube-nocookie.com/embed/u2vMnyTiwp4?si=pQ5wCNBqKnLG5u1v&amp;start=19" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
            </div>
          </div>

          <div class="sub-tab">
            <button class="sub-tab-button" onclick="toggleSubTab('disorganizedMovement')">Disorganized or Catatonic Behaviour</button>
            <div id="disorganizedMovement" class="sub-tab-content">
              <p>Disorganized behavior means difficulty organizing one's actions or behaving inappropriately – someone might neglect hygiene, wear bizarre outfits (like a winter coat in summer), or have unpredictable emotional outbursts.</p>
            </div>
          </div>

          <div class="sub-tab">
            <button class="sub-tab-button" onclick="toggleSubTab('catatonicSymptoms')">Catatonic Symptoms</button>
            <div id="catatonicSymptoms" class="sub-tab-content">
              <p>Catatonic symptoms are at the extreme end of disorganized behavior: the person might become very rigid, unresponsive, or hold strange postures for extended periods, or alternatively, exhibit purposeless excessive movement.</p>
              <iframe width="560" height="315" src="https://www.youtube.com/embed/zAEJ-Jvndms?si=d7pjYzLY5TfH29oI&amp;end=24" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
            </div>
          </div>
        </div>
      </div>

      <div class="tab">
        <button class="tab-button" onclick="toggleTab('negative')">Negative symptoms</button>
        <div id="negative" class="tab-content">
          <ul>
            <li>Reduced emotional expression</li>
            <li>Lack of motivation</li>
            <li>Social withdrawal</li>
            <li>Diminished speech</li>
            <li>Inability to experience pleasure (anhedonia)</li>
          </ul>
        </div>
      </div>

      <div class="tab">
        <button class="tab-button" onclick="toggleTab('cognitive')">Cognitive symptoms</button>
        <div id="cognitive" class="tab-content">
          <p>Impaired attention, memory, and executive function</p>
        </div>
      </div>
    </div>
    <h2>Stages of Schizophrenia</h2>
    <h3>#1: Prodromal stage</h3>
    <p>The prodromal stage is characterized by subtle changes in behavior and mood. 
      It is a time when the person is beginning to experience symptoms of schizophrenia, but they are not yet severe enough to be noticed, 
      which makes it difficult to identify. Some symptoms include yet not limited to: social isolation, irritability, difficulty concentrating, and sleep disturbances.</p>
    <h3>#2 Active stage</h3>
    <p>This is the acute phase of schizophrenia, where the person experiences the core symptoms of psychosis such as hallucinations and delusions.</p>
    <h3>#3 Residual stage</h3>
    <p>Residual schizophrenia refers to a phase with reduced or less severe symptoms compared to the active (psychotic) phase.
      At this stage, the positive symptoms are typically absent.
      The person is likely to be experiencing negative symptoms, low motivation, low energy, depressed mood and so on.
      DSM-5-TR Update: The residual phase is no longer used for diagnostic purposes, but still useful clinically to describe symptom patterns in schizophrenia.
    </p>

    <h1>DSM-5 Diagnosis</h1>
    <p><strong>To diagnose schizophrenia, the following criteria (A–F) must be met:</strong></p>
    <div class="info-block">
      <p>📝 <strong>Quick Summary:</strong></p>
      <ul>
        <li><strong>≥2 characteristic symptoms</strong> (delusions, hallucinations, disorganized speech) for <strong>≥1 month</strong></li>
        <li><strong>≥6 months</strong> continuous signs of disturbance</li>
        <li><strong>Significant functional decline</strong> in work, relationships, or self-care</li>
        <li><strong>Rule out</strong> mood disorders, substance use, and medical conditions</li>
      </ul>
    </div>

    <details>
      <summary>A. Characteristic Symptoms</summary>
      <div class="details-content">
        <p>Two (or more) of the following, each present for a significant portion of time during a 1-month period (or less if successfully treated).
        <strong>At least one</strong> must be (1), (2), or (3):</p>
        <ol>
          <li>Delusions</li>
          <li>Hallucinations</li>
          <li>Disorganized speech (e.g., frequent derailment or incoherence)</li>
          <li>Grossly disorganized or catatonic behavior</li>
          <li>Negative symptoms (e.g., diminished emotional expression or avolition)</li>
        </ol>
      </div>
    </details>

    <details>
      <summary>B. Social/Occupational Dysfunction</summary>
      <div class="details-content">
        <p>For a significant portion of the time since onset, level of functioning in one or more major areas such as work, interpersonal relations, or self-care is markedly below the level achieved prior to onset.</p>
      </div>
    </details>

    <details>
      <summary>C. Duration</summary>
      <div class="details-content">
        <p>Continuous signs of the disturbance persist for at least 6 months. This 6-month period must include at least 1 month of symptoms that meet Criterion A (active-phase symptoms) and may include periods of prodromal or residual symptoms.</p>
      </div>
    </details>

    <details>
      <summary>D. Schizoaffective and Mood Disorder Exclusion</summary>
      <div class="details-content">
        <p>Schizoaffective disorder and depressive or bipolar disorder with psychotic features have been ruled out because either:</p>
        <ul>
          <li>No major depressive or manic episodes have occurred concurrently with the active-phase symptoms; or</li>
          <li>If mood episodes have occurred during active-phase symptoms, they have been present for a minority of the total duration.</li>
        </ul>
      </div>
    </details>

    <details>
      <summary>E. Substance/Medical Condition Exclusion</summary>
      <div class="details-content">
        <p>The disturbance is not attributable to the physiological effects of a substance or another medical condition.</p>
      </div>
    </details>

    <details>
      <summary>F. Autism Spectrum Disorder Exclusion</summary>
      <div class="details-content">
        <p>If there is a history of autism spectrum disorder or a communication disorder of childhood onset, a diagnosis of schizophrenia is made only if prominent delusions or hallucinations are also present for at least 1 month (or less if successfully treated).</p>
      </div>
    </details>
  
    <h1>Diagnostic Challenges in Schizophrenia</h1>
    <details>
      <summary>No definitive lab tests or brain scans</summary>
      <div class="details-content">
        <ol>
          <li>Schizophrenia is diagnosed clinically, based on observed symptoms and illness course.</li>
          <li>Diagnosis relies on interviews with the patient and family and careful observation over time.</li>
        </ol>
      </div>
    </details>
    
    <details>
      <summary>Early-stage uncertainty</summary>
        <div class="details-content">
          <ol>
            <li>In the first few weeks or months, it may be unclear whether the case is:</li>
            <ul>
              <li>Schizophrenia</li>
              <li>A brief psychotic episode</li>
              <li>Mood-related psychosis</li>
            </ul>
            <li>Clinicians may delay diagnosis until the clinical picture becomes clearer.</li>
          </ol>
        </div>
    </details>

    <details>
      <summary>Symptom Overlap with Other Disorders</summary>
        <div class="details-content">
          <ol>
            <li>Severe depression</li>
            <ul>
              <li>Can cause delusional guilt or even hallucinations.</li>
            </ul>
            <li>Bipolar mania</li>
            <ul>
              <li>May include psychotic features such as grandiosity or hallucinations.</li>
            </ul>
            <li>Drug-induced psychosis</li>
            <ul>
              <li>Methamphetamine use or other substance intoxication can mimic schizophrenia symptoms in the short term.</li>
            </ul>
            <li>Conclusion:</li>
            <ul>
              <li>Diagnosing schizophrenia requires evaluating:</li>
              <li>Symptom duration</li>
              <li>Context (e.g., presence or absence of drug use)</li>
              <li>Mood symptoms</li>
            </ul>
            <li>Clinicians must "piece together the puzzle" carefully.</li>
          </ol>
        </div>
    </details>
    
    <details>
      <summary>Comorbid Conditions and Limited Insight</summary>
      <div class="details-content">
        <ul>
          <li><strong>Comorbidities are common</strong>
            <ul>
              <li>Anxiety disorders</li>
              <li>Depression</li>
              <li>Substance abuse</li>
            </ul>
          </li>
          <li>These can <strong>muddy the clinical picture</strong>, making diagnosis more complex.</li>
          <li><strong>Limited insight</strong>
            <ul>
              <li>Patients may <strong>not report hallucinations or delusions</strong>, especially early on, due to:
                <ul>
                  <li><strong>Fear</strong></li>
                  <li><strong>Paranoia</strong></li>
                  <li><strong>Distrust</strong></li>
                </ul>
              </li>
              <li>Families may only notice a person has <strong>"changed"</strong>, without understanding the cause.</li>
            </ul>
          </li>
        </ul>
      </div>
    </details>
    
    <details>
      <summary>Diagnostic Delay and Its Causes</summary>
      <div class="details-content">
        <ul>
          <li>Diagnosis often occurs <strong>months or even a year or more</strong> after symptom onset.</li>
          <li><strong>Contributing factors</strong>:
            <ul>
              <li><strong>Diagnostic complexity</strong></li>
              <li><strong>Social stigma</strong>, which may lead families to <strong>avoid seeking psychiatric help</strong></li>
            </ul>
          </li>
        </ul>
      </div>
    </details>
    
    <details>
      <summary>The Diagnostic Process</summary>
      <div class="details-content">
        <ul>
          <li>Mental health professionals are trained to:
            <ul>
              <li>Recognize <strong>schizophrenia symptom patterns</strong></li>
              <li>Conduct <strong>thorough interviews</strong></li>
              <li>Use <strong>psychological tests</strong> or <strong>standardized questionnaires</strong> when needed</li>
            </ul>
          </li>
          <li>A clear diagnosis helps shape an <strong>appropriate treatment plan</strong>.</li>
        </ul>
      </div>
    </details>
    
    <details>
      <summary>Schizophrenia as a Spectrum Disorder</summary>
      <div class="details-content">
        <ul>
          <li>Schizophrenia is <strong>not all-or-nothing</strong>; it exists on a <strong>spectrum</strong>.</li>
          <li><strong>Variability in symptom patterns and outcomes</strong>:
            <ul>
              <li>Some individuals have <strong>severe, chronic symptoms</strong></li>
              <li>Others may:
                <ul>
                  <li>Have <strong>one or two episodes</strong> then recover</li>
                  <li>Show mainly <strong>negative symptoms</strong> (e.g., lack of motivation) with few positive symptoms</li>
                </ul>
              </li>
            </ul>
          </li>
          <li>Hence, the term <strong>"schizophrenia spectrum disorders"</strong> is often used.</li>
        </ul>
      </div>
    </details>
    
    <details>
      <summary>Hope and Recovery</summary>
      <div class="details-content">
        <ul>
          <li><strong>Outcomes vary</strong>, even for those with full schizophrenia diagnoses.</li>
          <li>With <strong>support and treatment</strong>:
            <ul>
              <li>Many people can live <strong>fulfilling lives</strong>.</li>
              <li><strong>Success stories exist</strong> but are underrepresented in media.</li>
            </ul>
          </li>
          <li><strong>Important reminder</strong>:
            <ul>
              <li>A diagnosis of schizophrenia is <strong>serious</strong>, but <strong>not the end of one's aspirations</strong>.</li>
            </ul>
          </li>
        </ul>
      </div>
    </details>
  </section>

<section id="treatment">
  <div class="blog-content-wrapper">
    <h1>Treatment & Management</h1>
    <img src="https://media.istockphoto.com/id/1322211571/vector/group-therapy-addiction-treatment-concept-characters-counseling-with-psychologist-on.jpg?s=612x612&w=0&k=20&c=moDxi4u07wOzgiiuS2HK66dJzpsfRHkIk1ITTI5NbeE=" alt="Treatment" style="width: 100%; height: auto; margin: 20px 0;">  
    <p>While there's no cure for schizophrenia yet, effective treatments are available in helping patients manage symptoms, reduce relapses, and improve functioning. 
      Early identification and intervention may prevent or delay schizophrenia development and improve overall quality of life.</p>
    
    <h2>Medications</h2>
    <p>Antipsychotic medications are the cornerstone of treatment:</p>
    <img src="https://ourworldindata.org/cdn-cgi/imagedelivery/qLq-8BTgXU8yG0N6HnOy8g/8b0c0fa4-d146-4d13-d62e-083556a25f00/w=1350" 
         alt="Development of Antipsychotic Medications" 
         class="zoomable-image" 
         style="width: 100%; height: auto;"
         onclick="openModal(this)">
    
    <!-- Modal -->
    <div id="imageModal" class="modal" onclick="closeModal()">
      <img class="modal-content" id="modalImage">
    </div>

    <h3>Medication Types</h3>
    <div class="medication-container">
      <div class="medication-card" data-category="fga">
        <h3>First-Gen Antipsychotics</h3>
        <p><strong>Mechanism:</strong> Primarily block dopamine D2 receptors.</p>
        <p><strong>Examples:</strong> Haloperidol, Chlorpromazine.</p>
        <p><strong>Effectiveness:</strong> Strong for positive symptoms.</p>
        <p><strong>Side Effects:</strong> High risk of EPS, sedation, tardive dyskinesia.</p>
        <p class="source">(Source: bap.org.uk)</p>
      </div>
  
      <div class="medication-card" data-category="sga">
          <h3>Second-Gen Antipsychotics</h3>
          <p><strong>Mechanism:</strong> Block D2 and 5-HT2A receptors.</p>
          <p><strong>Examples:</strong> Risperidone, Olanzapine, Quetiapine.</p>
          <p><strong>Effectiveness:</strong> As effective as FGAs for positive symptoms, better tolerability.</p>
          <p><strong>Side Effects:</strong> Weight gain, metabolic syndrome, sedation.</p>
          <p class="source">(Source: bap.org.uk)</p>
      </div>
  
      <div class="medication-card" data-category="clozapine">
          <h3>Clozapine</h3>
          <p><strong>Mechanism:</strong> Modulates serotonin, dopamine, and others.</p>
          <p><strong>Effectiveness:</strong> Most effective for treatment-resistant schizophrenia, reduces suicide risk.</p>
          <p><strong>Side Effects:</strong> Agranulocytosis (requires monitoring), weight gain, seizures, sedation.</p>
          <p class="source">(Source: psychiatryonline.org)</p>
      </div>
  
      <div class="medication-card" data-category="karxt">
          <h3>KarXT (Cobenfy)</h3>
          <p><strong>Mechanism:</strong> Targets muscarinic acetylcholine receptors.</p>
          <p><strong>Effectiveness:</strong> Significant reduction in positive symptoms, promising fewer side effects.</p>
          <p><strong>Side Effects:</strong> Early trials suggest fewer sedation, weight gain, or motor issues.</p>
          <p class="source">(Source: fda.gov, npr.org)</p>
      </div>
    </div>

    <h2>Therapies & Supports</h2>
    <p>Comprehensive treatment includes:</p>
    <table>
        <thead>
            <tr>
                <th>Intervention</th>
                <th>Effectiveness</th>
                <th>Limitations</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td><strong>Cognitive Behavioral Therapy for Psychosis (CBTp)</strong></td>
                <td>• Helps patients reframe and cope with delusions/hallucinations<br>• Reduces distress and improves insight into symptoms</td>
                <td>• Does not eliminate psychotic symptoms<br>• Most effective when combined with medication</td>
            </tr>
            <tr>
                <td><strong>Psychoeducation</strong></td>
                <td>• Improves patient and family understanding of the illness and its treatment<br>• Helps with medication adherence and recognizing relapse signs</td>
                <td>• Relies on participant engagement and access to trained facilitators</td>
            </tr>
            <tr>
                <td><strong>Family Therapy</strong></td>
                <td>• Reduces relapse by lowering family stress and criticism ("expressed emotion")<br>• Improves family dynamics and communication</td>
                <td>• Not all families have time, resources, or willingness to participate</td>
            </tr>
            <tr>
                <td><strong>Social Skills & Rehabilitation Programs</strong></td>
                <td>• Teach life skills, job readiness, and foster independence<br>• Help reduce isolation and improve social function</td>
                <td>• Gains may be gradual<br>• Access to quality programs varies by location</td>
            </tr>
            <tr>
                <td><strong>Assertive Community Treatment (ACT)</strong></td>
                <td>• Reduces hospitalizations<br>• Improves medication adherence<br>• Helps with housing and daily care<br>• Highly effective for individuals with severe or persistent symptoms</td>
                <td>• Resource-intensive<br>• May not be available in all regions</td>
            </tr>
            <tr>
                <td><strong>Adjunctive Therapies (Art, Cognitive Remediation, Lifestyle)</strong></td>
                <td>• Art/music therapy promotes engagement and expression<br>• Cognitive remediation helps improve memory and attention<br>• Lifestyle education targets diet, exercise, smoking cessation</td>
                <td>• Limited evidence for standalone use<br>• Often require motivation and structured support</td>
            </tr>
            <tr>
                <td><strong>Early Intervention Programs</strong></td>
                <td>• Specialized clinics for first-episode psychosis significantly improve outcomes<br>• Reduce duration of untreated psychosis (DUP), linked to better long-term functioning<br>• Offer a full suite of services: meds, therapy, school/work support, family outreach<br><span class="source">(Source: emedicine.medscape.com)</span></td>
                <td>• Most effective in first few years; long-term effects depend on continued support<br>• May not be accessible in rural or under-resourced areas</td>
            </tr>
        </tbody>
    </table>

    <div class="info-block">
      <p>💡 <strong>Early Intervention</strong></p>
      <p>Early detection and treatment significantly improve outcomes:</p>
      <ul>
        <li>Recognition of prodromal symptoms</li>
        <li>Rapid access to specialized care</li>
        <li>Coordinated specialty care programs</li>
      </ul>
    </div>

    <h2>Hope, Challenges, Needs and Research Directions</h2>
    <p>There is no one-size-fits-all solution — effective care requires a multi-disciplinary, personalized approach involving medication, therapy, community support, and patient involvement.</p>
    <div class="symptoms-tabs">
      <div class="tab">
        <button class="tab-button" onclick="toggleTab('hopes')">🌟 Hopes</button>
        <div id="hopes" class="tab-content">
          <ul>
            <li><strong>Symptom Control and Stability:</strong> Most individuals with schizophrenia can experience significant symptom relief—especially of positive symptoms like hallucinations and delusions—through antipsychotic medication.</li>
            <li><strong>New Drug Development:</strong> The 2024 FDA approval of KarXT (Cobenfy) marks a major breakthrough. Unlike traditional antipsychotics, KarXT does not primarily block dopamine receptors and has shown fewer side effects like sedation and weight gain.</li>
            <li><strong>Early Intervention Works:</strong> Specialized early psychosis programs can dramatically improve long-term outcomes if treatment is initiated early, especially in youth.</li>
            <li><strong>Recovery-Oriented Care:</strong> The modern emphasis on holistic, person-centered approaches—including peer support and vocational rehab—offers hope for meaningful, independent lives, even if some symptoms persist.</li>
          </ul>
          <p class="source">(Sources: bap.org.uk, fda.gov, npr.org, emedicine.medscape.com)</p>
        </div>
      </div>

      <div class="tab">
        <button class="tab-button" onclick="toggleTab('challenges')">⚠️ Challenges</button>
        <div id="challenges" class="tab-content">
          <ul>
            <li><strong>Adherence Issues:</strong> Medication non-adherence remains a critical issue, often due to side effects or lack of insight into the illness. Long-acting injectables can help, but uptake varies.</li>
            <li><strong>Treatment-Resistant Cases:</strong> About 25% of patients do not respond to standard antipsychotics. Clozapine is the best option in these cases but carries serious risks like agranulocytosis, requiring strict monitoring.</li>
            <li><strong>Side Effects and Metabolic Issues:</strong> Many antipsychotics, especially second-generation ones, cause significant weight gain and metabolic syndrome, increasing the risk of diabetes and heart disease.</li>
            <li><strong>Negative and Cognitive Symptoms:</strong> Current treatments are less effective for negative symptoms (e.g., social withdrawal, lack of motivation) and cognitive deficits. These symptoms often impair real-world functioning even when psychosis is controlled.</li>
            <li><strong>Relapse Risk:</strong> Schizophrenia has a relapsing-remitting course. Each relapse can worsen long-term outcomes. Preventing them requires continuous care and early detection of warning signs.</li>
            <li><strong>Stigma:</strong> Stigma remains a major barrier throughout treatment, leading to non-adherence, social withdrawal, or shame. It reduces engagement with care, making education, empathy, and peer support essential to counter hopelessness and promote recovery.</li>
          </ul>
          <p class="source">(Sources: bap.org.uk, psychiatryonline.org)</p>
        </div>
      </div>

      <div class="tab">
        <button class="tab-button" onclick="toggleTab('needs')">🚨 Pressing Needs</button>
        <div id="needs" class="tab-content">
          <ul>
            <li><strong>Better Tolerated Medications:</strong> There's a strong need for antipsychotics with fewer motor, cognitive, and metabolic side effects to improve adherence and long-term health outcomes.</li>
            <li><strong>Targeting Negative Symptoms and Cognition:</strong> Existing drugs are largely ineffective for the most disabling aspects of the disorder. New treatments must address this gap to improve quality of life and functional recovery.</li>
            <li><strong>Accessible Early Intervention Services:</strong> Programs for first-episode psychosis are not yet widely available, particularly in rural or underfunded areas, despite their proven efficacy.</li>
            <li><strong>Culturally Sensitive, Integrated Care:</strong> Tailored treatment that respects cultural differences, includes family, and provides coordinated care (e.g., through Assertive Community Treatment teams) is essential but inconsistently applied.</li>
          </ul>
        </div>
      </div>

      <div class="tab">
        <button class="tab-button" onclick="toggleTab('research')">🔬 Research Directions</button>
        <div id="research" class="tab-content">
          <ul>
            <li><strong>Non-Dopamine-Based Therapies:</strong> KarXT's success shows promise for non-dopaminergic pathways—like the muscarinic acetylcholine system. Other targets being explored include glutamate modulation and inflammation pathways.</li>
            <li><strong>Digital and Tech-Enabled Care:</strong> Tools like smartphone apps for symptom monitoring and early relapse detection, and virtual reality for social skills training, are being developed to support engagement and autonomy.</li>
            <li><strong>Cognitive Remediation & Lifestyle Integration:</strong> Combining therapies that enhance memory and attention with lifestyle interventions (e.g., diet, exercise, smoking cessation) may improve both mental and physical health outcomes.</li>
            <li><strong>Recovery Model Integration:</strong> There's a growing emphasis on shifting away from a purely clinical focus to one that enables individuals to pursue education, work, relationships, and creative goals, even with lingering symptoms.</li>
          </ul>
          <p class="source">(Sources: fda.gov, npr.org)</p>
        </div>
      </div>
    </div>
  </div>
</section>

<section id="conclusion">
  <div class="content-column" style="flex: 100%;">
    <h1>Key Takeaways & Future</h1>
    <p>Schizophrenia is a serious but treatable mental health condition. With the right mix of medication, therapy, and community support, people can lead fulfilling lives. We must:</p>
    <ul>
      <li>Reduce stigma and discrimination</li>
      <li>Improve access to quality care</li>
      <li>Invest in ongoing research</li>
      <li>Develop more effective treatments</li>
      <li>Enhance early intervention programs</li>
    </ul>
  </div>
</section>

  <script src="script.js"></script>
  <button id="backToTopBtn" title="Back to Top"></button>
  
  <footer>
    <p>&copy; 2025 Anran Huang. All rights reserved.</p>
  </footer>
</body>
</html>
